Best private label biotin supplement manufacturers

Buyer criteria

• Micro-dose blend uniformity capability

  The defining qualification for a biotin manufacturer is how it distributes a microgram-scale active evenly across hundreds of thousands of units. Ask specifically about the trituration or serial pre-blend method, how many dilution stages are used, and how uniformity is validated. A house that cannot describe a deliberate micro-dose strategy will produce a batch with hot spots, where some units are over-dosed and others under-dosed, failing label-claim testing on the very ingredient your brand is built around.

• Finished-product biotin assay against label claim

  Confirm the manufacturer assays the actual biotin content of finished units against the label claim, sampled across the batch rather than once, since uniformity is the risk. A blend uniformity plan is only credible if proven by finished-product testing. Ask to see assay data demonstrating the dose holds across the run. Without it you cannot prove your micro-dose product delivers what the label says, which is the core compliance risk in this category.

• Gummy capability and vegan gelling, if relevant

  If you want a gummy, which dominates the beauty-biotin segment, confirm the manufacturer runs gummy production in-house and, for vegan claims, uses a pectin or agar gelling system rather than gelatin. Gummies are a specialist confectionery-style process distinct from capsule filling, with their own uniformity challenge as the active must disperse through liquid gel. A capsule house that subcontracts gummies adds cost and removes your control over texture and dose accuracy.

• Co-active stack formulation

  Biotin is rarely sold alone in beauty products, usually anchoring a hair-skin-nail stack with zinc, selenium, vitamin C or collagen. Confirm the manufacturer can formulate and evenly distribute multiple actives at very different inclusion scales simultaneously, and that each co-active is dosed to a meaningful, defensible level. Ask how uniformity is verified for both the trace biotin and the supporting actives, since a beauty stack that is fairy-dusted beyond the biotin misleads buyers.

• Clean-label and vegan substantiation

  Beauty-from-within buyers often expect vegan, gelatin-free and clean-label products, so confirm the gelling agent, the absence of unwanted excipients, and any vegan or clean-label claims can be substantiated. For gummies, the difference between gelatin and a vegan pectin system is fundamental to the claim. Verify the formulation matches the positioning, since a vegan claim contradicted by a gelatin gummy or an undisclosed animal-derived ingredient is both a trust and a compliance failure.

• Gummy stability and texture control

  Gummies degrade in texture and can lose actives or grow sticky if stability and moisture are not controlled, so confirm the manufacturer runs stability testing on the gummy format and packaging and controls moisture in production and packing. Ask for stability data on your actual product. A beauty gummy that clumps, hardens or sweats in the bottle fails the daily-use experience that drives reorder, regardless of how good the biotin assay looks on day one.

• GMP and certification scope for your format

  Require current GMP and food-safety certification with a scope that explicitly covers your format, since gummy and capsule production are distinct processes. Confirm the certification covers confectionery-style gummy manufacturing if that is your format. Ask for representative assay and uniformity data rather than generic assurances. A certificate scoped only for capsules does not validate a gummy line, and format-process mismatch is a common gap behind quality failures.

Manufacturing process

1. 01

   Dose definition and trituration planning

   The brand fixes the biotin dose, commonly 5,000 or 10,000 micrograms, and the manufacturer plans how to distribute that trace quantity evenly across the batch. Because the active is microgram-scale in a milligram-scale unit, a trituration or pre-blend strategy is designed up front: the biotin is diluted into a carrier in controlled stages. This planning is the defining technical decision, since it determines whether every unit will meet the label claim.

2. 02

   Biotin procurement and verification

   Pharmaceutical-grade biotin is procured to a specification for purity and potency and tested on receipt. The active is inexpensive and stable, so cost and supply are rarely limiting, but identity and potency verification still matter because the finished-product assay against label claim begins with a verified raw material. The grade and purity of the biotin are confirmed before it enters the uniformity-critical blending stages.

3. 03

   Trituration and serial pre-blending

   The trace biotin is blended with a small amount of carrier, then that pre-blend is diluted into progressively larger quantities in stages, building up the full batch while keeping the active evenly dispersed. This serial dilution prevents hot spots where biotin concentrates in some units and is absent from others. The number of stages and the mixing validation at each step are what separate a uniform micro-dose batch from a non-compliant one.

4. 04

   Co-active blending

   Supporting hair-skin-nail actives, zinc, selenium, vitamin C, collagen or others, are blended in to their own uniformity targets alongside the biotin. Some co-actives are bulk ingredients while others are also low-inclusion, so the blend must handle multiple ingredients at very different scales simultaneously. Blend uniformity is sampled top, middle and bottom to confirm both the trace biotin and the co-actives distribute evenly across the full batch.

5. 05

   Format production: capsule, tablet, or gummy

   For capsules and tablets the uniform blend is encapsulated or compressed with in-process weight checks. For gummies, the biotin and co-actives are dosed into a cooked gel base (gelatin or a vegan pectin or agar system), deposited into molds, set, and demolded, which is a confectionery-style process with its own uniformity challenge since the active must distribute evenly through the liquid gel before setting. The format is matched to the brand's beauty positioning.

6. 06

   Gummy finishing or capsule polishing

   Gummies are dried or cured to the target texture, then coated or sugar-sanded and tumbled to prevent sticking, while capsules and tablets are polished and metal-detected. Gummy texture, sweetness and the absence of stickiness drive the consumer experience that beauty buyers judge daily. Each format's finishing is tuned to deliver a product that looks and feels premium on a beauty shelf rather than like a clinical supplement.

7. 07

   Quality control and biotin assay

   QC assays the biotin content of finished units against label claim, the critical test for a micro-dose product, along with co-active content, microbiological limits and, for gummies, moisture and texture. Because the dose is so small, uniformity is verified across the batch, not just on a single sample. Per-batch certificates of analysis document the biotin and co-active content, proving the label claim holds across the production run.

8. 08

   Packaging, labeling and lot coding

   Units are bottled, blistered or pouched, labeled with the biotin dose, co-actives, any vegan or clean-label claims, lot code and expiry, then sealed and palletized. Gummies are packed to control moisture and prevent clumping. Lot codes trace finished product back to the biotin and co-active lots, supporting any uniformity or potency investigation, which matters precisely because the active is a trace ingredient.

Understanding biotin supplement private-label manufacturing

Biotin supplements deliver a B-vitamin at a microgram-scale dose, and that single fact, that the active is measured in micrograms while the capsule or gummy weighs hundreds of milligrams, defines the entire manufacturing challenge of the category. For a private label brand, biotin is a hair, skin and nail product where the hard part is not sourcing the vitamin, which is cheap and widely available, but distributing a tiny quantity of it evenly across hundreds of thousands of units so that every single one carries the labeled dose. A common 5,000 or 10,000 microgram biotin product contains a vanishingly small amount of active in a large carrier, and blend uniformity is the whole game. This makes biotin different from a bulk active like magnesium or protein, where the active dominates the fill. Here the active is a trace ingredient, so the manufacturer must use trituration or pre-blending, diluting the biotin into a carrier in stages, to avoid hot spots where some units are over-dosed and others under-dosed. A house that simply throws raw biotin into a large blender will produce a batch where the dose varies wildly from capsule to capsule, which fails label-claim testing and exposes the brand. The technical credibility of a biotin manufacturer is judged almost entirely on how it handles micro-dose uniformity. Biotin finishing for the European market is handled by capsule, tablet and gummy houses across Germany, the Netherlands, Italy, Poland and the UK, with the biotin active sourced from specialist vitamin producers globally. The biotin supplement market was valued at roughly 3.72 billion USD in 2024 and is projected to reach about 10.60 billion USD by 2034 at around 11.04 percent CAGR (Precedence Research), one of the faster-growing single-vitamin categories, driven by beauty-from-within and hair-health demand, particularly in gummy format. The growth is led by D2C beauty positioning rather than clinical use. Sourcing reality is shaped by how cheap the active is and how popular the gummy format has become. MOQs for biotin capsules or tablets can start relatively low, often 3,000 to 10,000 units for a custom SKU, while gummies carry higher floors because of their batch-cooking process. Lead times run 6 to 12 weeks. Cost drivers, in order, are the format (gummies cost more than tablets or capsules and dominate the beauty segment), the co-actives such as zinc, selenium, collagen or other hair-skin-nail ingredients that often accompany biotin, the packaging, and only then the biotin itself, which is a minor line item. Because the active is cheap, brands rarely compete on biotin cost and instead differentiate on format, stack and positioning. Private label biotin buyers are overwhelmingly beauty-from-within and hair-health D2C brands, followed by general wellness brands, retailer beauty-supplement ranges, and gummy-led brands targeting a younger, taste-driven audience. Differentiation runs on the format (gummy versus capsule), the supporting hair-skin-nail stack, clean-label and vegan positioning (gummies require a vegan gelling agent for vegan claims), and dose. Qualifying a partner on micro-dose blend uniformity, on whether they assay finished product against the biotin label claim, and on gummy capability where relevant matters more than headline price, because a biotin product that fails uniformity delivers an inconsistent dose that no amount of attractive packaging can fix.

Industry insights

Frequently asked questions

Explore adjacent product types